跳至主要内容
临床试验/NCT01255475
NCT01255475已完成2 期

Effect of Blood Pressure Reduction in Patients With Chronic Heart Failure - Randomized, Double-blind, Placebo-controlled Trial

University of Sao Paulo1 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2011年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
21
试验地点
1
主要终点
Any cause mortality

研究概览

简要总结

Previous studies have demonstrated a direct association between blood pressure level and cardiovascular risk. However in patients with heart failure this association is considered controversial. The aim of this study is to evaluate the effect of the reduction of blood pressure in patients with heart failure. The investigators will examine the effects of this intervention over mortality, quality of life, and cardiac function.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • stable chronic heart failure for at least 6 months
  • ejection fraction of 40% or less, as measured by transthoracic echocardiography
  • optimal clinical treatment for chronic heart failure according to current international guidelines.

排除标准

  • patient refusal
  • rheumatic or degenerative valvular disease
  • restrictive cardiomyopathy
  • evidence of myocardial ischemia
  • alcohol or drug use
  • malignant neoplasm
  • active infection
  • surgical intervention in the 3 previous months
  • lactation, childbearing or childbearing potential.
  • pulmonary embolism in the 6 previous months

研究组 & 干预措施

Intervention

Experimental

干预措施: Hydralazine/amlodipine (Drug)

Control

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Any cause mortality

时间窗: 12 months after randomization

Unplanned hospital admission from any cause

时间窗: 12 months after randomization

次要结局

  • Cardiovascular death(12 months after randomization)
  • Acute myocardial ischemia(12 months after randomization)
  • Stroke(12 months after randomization)
  • Symptomatic hypotension(12 months after randomization)
  • Renal function(12 months after randomization)
  • Peak exercise oxygen consumption(12 months after randomization)
  • Quality of life(12 months after randomization)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Edimar Alcides Bocchi

Heart Failure Team Directos

University of Sao Paulo

研究点 (1)

Loading locations...

相似试验

Blood Pressure Reduction in Heart Failure | 临床试验